Arcus Biosciences

Forecast & Rating13 analysts currently cover Arcus Biosciences, with about 76.9% giving a positive rating — meaning they expect the stock to rise. The average price target is $38.33, about 28.5% upside from the current price of $29.84. Price targets range from $23.00 to $47.00 — a wide spread, showing clear disagreement over just how much Arcus Biosciences can rise. Historically, about 0.8% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Arcus Biosciences closely still see room for the stock to rise. Data as of Aug 19, 2026; for reference only and not investment advice.